ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suter, S
Right arrow Articles by Chevallier, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suter, S
Right arrow Articles by Chevallier, I
Eur Respir J 1991; 4: 40-49
Copyright © ERS Journals Ltd 1991


Original Articles

Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis

S Suter and I Chevallier

The chronic, progressively destructive bronchitis of patients with cystic fibrosis (CF) is characterized by an important imbalance between tissue destroying granulocyte proteases such as granulocyte elastase (GE) and its physiological inhibitors in bronchial secretions. Recent in vitro studies suggest, that proteases derived from bacteria or endogenous proteases may contribute to inactivation of physiological inhibitors of GE. Since only trypsin-unreactive alpha 1-proteinase inhibitor (alpha 1-PI) was detected in CF bronchial secretions, we attempted to identify the mechanism of inactivation of alpha 1-PI. We found a heat stable, serine protease-like enzymatic activity capable of degrading 125I-labelled alpha 1-PI extensively in 22 infected but not in one non-infected CF bronchial secretion. In infected secretions, only degraded alpha 1-PI, which did not migrate like oxidized alpha 1-PI in tandem-crossed immunoelectrophoresis, was detectable. We conclude, that free GE in excess as well as GE bound to bronchial mucosal inhibitor may partly account for the alpha 1-PI-cleaving activity, but that other yet unknown bacterial or host serine proteases also contribute to alpha 1-PI inactivation.


This article has been cited by other articles:


Home page
Eur Respir JHome page
M. Griese, P. Latzin, M. Kappler, K. Weckerle, T. Heinzlmaier, T. Bernhardt, and D. Hartl
{alpha}1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Eur. Respir. J., February 1, 2007; 29(2): 240 - 250.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Attucci, A. Gauthier, B. Korkmaz, P. Delepine, M. F.-D. Martino, F. Saudubray, P. Diot, and F. Gauthier
EPI-hNE4, a Proteolysis-Resistant Inhibitor of Human Neutrophil Elastase and Potential Anti-Inflammatory Drug for Treating Cystic Fibrosis
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 803 - 809.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamaoka, K.-i. Masuda, H. Ogawa, K.-i. Takagi, N. Umemoto, and S. Yasuoka
Cloning and Characterization of the cDNA for Human Airway Trypsin-like Protease
J. Biol. Chem., May 8, 1998; 273(19): 11895 - 11901.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. D. Rees, J. D. Brain, M. E. Wohl, J. L. Humes, and R. A. Mumford
Inhibition of Neutrophil Elastase in CF Sputum by L-658,758
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1201 - 1206.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the European Respiratory Society.